Pyridine-containing compound metabolic process

pathway activity — cross-omics
GO:0072524Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyridine-containing compound metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CCDC69, CYTH4, and CCRL2, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyridine-containing compound metabolic process activity versus CCDC69 in BRCA (Pearson r = 0.20).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACCDC69 →+0.819+0.228<.001<.00138
HNSCCYTH4 →+1.045+0.164<.001<.00137
GBMCCRL2 →+0.796+0.173<.001<.00137
GBMGPR65 →+0.628+0.123.003.00337
GBMMYO1F →+0.891+0.180<.001<.00137
BRCARAB37 →+0.604+0.165.001.00337
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072524 vs CCDC69 — BRCA

Per-sample scatter of Pyridine-containing compound metabolic process activity vs CCDC69 in BRCA.

Explore this scatter interactively →

Exploration